Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | KDM5A | P29375 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21324002 | 1.00 | CES2 (0.31) | CES2CA12CA1CA2CA9 | |
| SCHEMBL22035307 | 0.92 | CES2 (0.32) | CES2CA12CA1CA2CA9 | |
| SCHEMBL20778802 | 0.89 | CA12 (0.33) | CES2CA12CA1CA2CA9 | |
| SCHEMBL27341113 | 0.84 | CES2 (0.33) | CES2CA12CA1CA2CA9 | |
| SCHEMBL20115513 | 0.84 | CES2 (0.36) | CES2CA12CA1CA2CA9 | |
| SCHEMBL20628161 | 0.83 | CA12 (0.37) | CES2CA12CA1CA2CA9 | |
| SCHEMBL24557245 | 0.81 | CA12 (0.35) | CES2CA12CA1CA2CA9 | |
| SCHEMBL24597706 | 0.81 | — | — | |
| SCHEMBL24709510 | 0.80 | CA12 (0.34) | CES2CA12CA1CA2CA9 | |
| SCHEMBL23766685 | 0.78 | CA12 (0.37) | CES2CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3766916-A1 | NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS | Acuitas Therapeutics Inc. (CA) | 2021-01-20 | — | — | EP | disclosed |